- Report
- July 2025
- 112 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- March 2025
- 79 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- September 2025
- 135 Pages
Global
From €3678EUR$4,123USD£3,243GBP
€4328EUR$4,850USD£3,816GBP
- Report
- September 2025
- 135 Pages
Global
From €3678EUR$4,123USD£3,243GBP
€4328EUR$4,850USD£3,816GBP
- Report
- July 2025
- 140 Pages
Global
From €3678EUR$4,123USD£3,243GBP
€4328EUR$4,850USD£3,816GBP
- Report
- July 2025
- 150 Pages
United States
From €5309EUR$5,950USD£4,681GBP
- Report
- June 2025
- 300 Pages
Latin America
From €3452EUR$3,869USD£3,044GBP
- Report
- June 2025
- 90 Pages
United States
From €4328EUR$4,850USD£3,816GBP
- Report
- September 2023
- 303 Pages
Global
From €4636EUR$5,378USD£3,950GBP
- Report
- February 2024
- 202 Pages
Global
From €4461EUR$5,000USD£3,934GBP
- Report
- October 2022
- 194 Pages
Global
From €4461EUR$5,000USD£3,934GBP
- Report
- August 2023
- 115 Pages
Global
From €2008EUR$2,250USD£1,770GBP
- Report
- August 2025
- 200 Pages
Saudi Arabia
From €2222EUR$2,490USD£1,959GBP
- Report
- August 2023
- 370 Pages
Global
From €2222EUR$2,490USD£1,959GBP
- Report
- July 2023
- 210 Pages
Global
From €1776EUR$1,990USD£1,566GBP
- Report
- July 2023
- 110 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- July 2024
- 150 Pages
Global
From €2677EUR$3,000USD£2,360GBP
€3346EUR$3,750USD£2,950GBP
- Report
- February 2024
- 115 Pages
Global
From €4238EUR$4,750USD£3,737GBP
- Report
- February 2025
- 85 Pages
India
From €3123EUR$3,500USD£2,754GBP
- Report
- January 2024
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
€4328EUR$4,850USD£3,816GBP

The Adult Vaccine market is a segment of the larger Vaccine market, which focuses on providing immunizations to adults. Vaccines are used to protect adults from a variety of diseases, including influenza, hepatitis, and human papillomavirus. Vaccines are typically administered in a series of doses, and may require booster shots to maintain immunity. Vaccines are typically administered by healthcare professionals in a clinical setting, but some vaccines may be self-administered.
The Adult Vaccine market is highly competitive, with a variety of companies offering a range of products. Major players in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, and Johnson & Johnson. These companies offer a range of vaccines, including influenza, hepatitis, and human papillomavirus vaccines. Additionally, some companies offer combination vaccines, which provide protection against multiple diseases in a single dose. Show Less Read more